Interventional antimicrobial therapy in febrile neutropenic patients (Q33685834)

28 July 2017

1 reference

title

Interventional antimicrobial therapy in febrile neutropenic patients (English)

1 reference

28 July 2017

Maschmeyer G

1

1 reference

28 July 2017

publication date

1 July 1999

1 reference

Diagnostic Microbiology and Infectious Disease

28 July 2017

published in

1 reference

28 July 2017

volume

34

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

205-212

1 reference

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Prospective study of infections in indwelling central venous catheters using quantitative blood cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Advances in the management of Pseudomonas aeruginosa infections in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Symposium on infectious complications of neoplastic disease (Part II). Granulocyte transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Source and route of microbial colonisation of parenteral nutrition catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Assessment and reporting of clinical trials of empirical therapy in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900024-3

7 January 2021

10.1016/S0732-8893(99)00024-3

Identifiers

DOI

1 reference

28 July 2017

1 reference